125 related articles for article (PubMed ID: 14697785)
1. 2,6-Bis(3,4,5-trihydroxybenzylydene) derivatives of cyclohexanone: novel potent HIV-1 integrase inhibitors that prevent HIV-1 multiplication in cell-based assays.
Costi R; Santo RD; Artico M; Massa S; Ragno R; Loddo R; La Colla M; Tramontano E; La Colla P; Pani A
Bioorg Med Chem; 2004 Jan; 12(1):199-215. PubMed ID: 14697785
[TBL] [Abstract][Full Text] [Related]
2. 6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays.
Costi R; Di Santo R; Artico M; Roux A; Ragno R; Massa S; Tramontano E; La Colla M; Loddo R; Marongiu ME; Pani A; La Colla P
Bioorg Med Chem Lett; 2004 Apr; 14(7):1745-9. PubMed ID: 15026063
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.
Sun XH; Guan JQ; Tan JJ; Liu C; Wang CX
SAR QSAR Environ Res; 2012 Oct; 23(7-8):683-703. PubMed ID: 22991976
[TBL] [Abstract][Full Text] [Related]
4. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase.
Sun Y; Xu W; Fan N; Sun X; Ning X; Ma L; Liu J; Wang X
Bioorg Med Chem; 2017 Feb; 25(3):1076-1084. PubMed ID: 28082070
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
[TBL] [Abstract][Full Text] [Related]
9. Caffeoyl naphthalenesulfonamide derivatives as HIV integrase inhibitors.
Xu YW; Zhao GS; Shin CG; Zang HC; Lee CK; Lee YS
Bioorg Med Chem; 2003 Aug; 11(17):3589-93. PubMed ID: 12901903
[TBL] [Abstract][Full Text] [Related]
10. Closely related antiretroviral agents as inhibitors of two HIV-1 enzymes, ribonuclease H and integrase: "killing two birds with one stone".
Andréola ML
Curr Pharm Des; 2004; 10(30):3713-23. PubMed ID: 15579066
[TBL] [Abstract][Full Text] [Related]
11. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J
J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973
[TBL] [Abstract][Full Text] [Related]
12. New anti-HIV derivatives: synthesis and antiviral evaluation.
De Michelis C; Rocheblave L; Priem G; Chermann JC; Kraus JL
Bioorg Med Chem; 2000 Jun; 8(6):1253-62. PubMed ID: 10896105
[TBL] [Abstract][Full Text] [Related]
13. Chicoric acid analogues as HIV-1 integrase inhibitors.
Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
[TBL] [Abstract][Full Text] [Related]
14. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.
de Soultrait VR; Lozach PY; Altmeyer R; Tarrago-Litvak L; Litvak S; Andréola ML
J Mol Biol; 2002 Nov; 324(2):195-203. PubMed ID: 12441099
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.
Sharma H; Patil S; Sanchez TW; Neamati N; Schinazi RF; Buolamwini JK
Bioorg Med Chem; 2011 Mar; 19(6):2030-45. PubMed ID: 21371895
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors.
Carcelli M; Rogolino D; Sechi M; Rispoli G; Fisicaro E; Compari C; Grandi N; Corona A; Tramontano E; Pannecouque C; Naesens L
Eur J Med Chem; 2014 Aug; 83():594-600. PubMed ID: 24996145
[TBL] [Abstract][Full Text] [Related]
17. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
[TBL] [Abstract][Full Text] [Related]
18. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
[TBL] [Abstract][Full Text] [Related]
20. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]